Business Description

Description
Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The firm has developed Biochaperone, a proprietary technology platform to enhance the effectiveness of therapeutic proteins. The company's clinical pipeline includes Biochaperone Lispro, Biochaparone Combo, Biochaparone Glucagon, and others. Its pre-clinical pipeline includes BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.
Name Current Vs Industry Vs History
Cash-To-Debt 0.42
Equity-to-Asset -0.88
Debt-to-Equity -1.55
Debt-to-EBITDA -1.67
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.47
Distress
Grey
Safe
Beneish M-Score 3.6
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.6
Quick Ratio 0.59
Cash Ratio 0.43
Days Inventory 64.9
Days Sales Outstanding 24.42
Days Payable 481.21

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.8
Shareholder Yield % 1.67

Financials

ADOIF's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ADOIF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Adocia Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 6.104
EPS (TTM) ($) -2.672
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 8.871
12-1 Month Momentum % 0
52-Week Range ($) 8.871 - 8.871
Shares Outstanding (Mil) 11.69

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Adocia Filings

Filing Date Document Date Form
No Filing Data

Adocia Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Adocia Frequently Asked Questions

What is Adocia(ADOIF)'s stock price today?
The current price of ADOIF is $8.87. The 52 week high of ADOIF is $8.87 and 52 week low is $8.87.
When is next earnings date of Adocia(ADOIF)?
The next earnings date of Adocia(ADOIF) is .
Does Adocia(ADOIF) pay dividends? If so, how much?
Adocia(ADOIF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1